Cysteinyl-leukotriene receptor antagonism blunts the acute hypotensive response to endotoxin in cats
- PMID: 20719552
- PMCID: PMC11135526
- DOI: 10.1016/j.jfms.2010.05.012
Cysteinyl-leukotriene receptor antagonism blunts the acute hypotensive response to endotoxin in cats
Abstract
This study evaluated the effects of a cysteinyl-leukotriene-1 (cys-LT(1)) receptor antagonist, zarfirlukast, during feline endotoxemia. Six adult, sexually intact male cats received either placebo or zarfirlukast (10mg, PO) and endotoxin (2 μg/kg/h q 6h) in a cross-over design. Rectal temperature, heart rate, systolic arterial blood pressure, plasma tumor necrosis factor (TNF) activity, interleukin (IL)-6 concentration and urine cys-LT to creatinine ratio were evaluated. The rectal temperature, plasma TNF activity and IL-6 concentrations were significantly higher and systolic arterial blood pressure and heart rate significantly lower after endotoxin infusion. Cats treated with zafirlukast had a significantly higher blood pressure at 4h (P=0.002) compared to placebo. Urine cys-LT to creatinine ratio was significantly greater in the cats treated with zafirlukast compared to placebo (P=0.02). Zafirlukast administration ameliorated the acute hypotensive response to endotoxin in cats, but failed to significantly alter rectal temperature, heart rate or production of TNF and IL-6.
Copyright © 2010 ISFM and AAFP. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Treatment of canine atopic dermatitis with zafirlukast, a leukotriene-receptor antagonist: a single-blinded, placebo-controlled study.Can Vet J. 2002 Mar;43(3):203-6. Can Vet J. 2002. PMID: 11901593 Free PMC article. Clinical Trial.
-
Evaluation of the anti-endotoxin effects of polymyxin B in a feline model of endotoxemia.J Feline Med Surg. 2010 Apr;12(4):278-85. doi: 10.1016/j.jfms.2009.12.014. Epub 2010 Feb 13. J Feline Med Surg. 2010. PMID: 20156699 Free PMC article.
-
Cysteinyl leukotriene receptor type 1 (CysLT1R) antagonist zafirlukast protects against TNF-α-induced endothelial inflammation.Biomed Pharmacother. 2019 Mar;111:452-459. doi: 10.1016/j.biopha.2018.12.064. Epub 2018 Dec 27. Biomed Pharmacother. 2019. PMID: 30594784
-
[The role of leukotrienes in inflammation and leukotriene inhibitors].Pol Merkur Lekarski. 1999 Sep;7(39):85-93. Pol Merkur Lekarski. 1999. PMID: 10598480 Review. Polish.
-
Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.Ann Pharmacother. 1997 Sep;31(9):1012-21. doi: 10.1177/106002809703100912. Ann Pharmacother. 1997. PMID: 9296243 Review.
Cited by
-
The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.Eur J Clin Pharmacol. 2017 Jul;73(7):799-809. doi: 10.1007/s00228-017-2242-2. Epub 2017 Apr 4. Eur J Clin Pharmacol. 2017. PMID: 28374082 Review.
-
Contrasting actions of diesel exhaust particles on the pulmonary and cardiovascular systems and the effects of thymoquinone.Br J Pharmacol. 2011 Dec;164(7):1871-82. doi: 10.1111/j.1476-5381.2011.01442.x. Br J Pharmacol. 2011. PMID: 21501145 Free PMC article.
References
-
- Brady C.,Otto C.,Winkle T.,King L..Severe sepsis in cats: 29 cases (1986–1998).J Am Vet Med Assoc. 2000;217:531-535 - PubMed
-
- CostelloM.Sepsis panel – feline sepsis. ACVECC Postgraduate Course 2006: sepsis in veterinary medicine, 2006, San Francisco, CA
-
- Sergeeff J.,Armstrong P.J.,Bunch S.E..Hepatic abscesses in cats: 14 cases (1985–2002).J Vet Intern Med. 2004;18:295-300 - PubMed
-
- Costello M.,Drobatz K.,Aronson L..Underlying cause, pathophysiologic abnormalities, and response to treatment in cats with septic peritonitis: 51 cases (1990–2001).J Am Vet Med Assoc. 2004;225:897-902 - PubMed
-
- DeClueADelgadoCChangCSharpC. Clinical and immunologic assessment of sepsis and the systemic inflammatory response syndrome in cats. J Am Vet Med Assoc. In press 2010. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous